Medical Advocates
HIV Infection/Disease
  Non-Hodgkin Lymphoma Drugs
  

Antiretrovirals
Doxorubicin
Rituximab
Miscellaneous Therapies
    

     






 

Non-Hodgkin's Lymphoma Main New/Newsworthy Home Page

Last Update:  June 24, 2017
.Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Antiretrovirals
       

     Journal Papers, Abstracts, and Commentaries  

 
FULL-TEXT PDF ARTICLE
Early Development of non-Hodgkin Lymphoma Following Initiation of Newer
Class Antiretroviral Therapy Among HIV-infected Patients - Implications for
Immune Reconstitution.

Huhn GD, Badri S, Vibhakar S, et al

AIDS Res Ther
. 2010 Dec 14;7(1):44.
Paper

Highly Active Antiretroviral Therapy is Associated with Improved Survival among Patients with
AIDS-Related Primary Central Nervous System
Diamond C, Taylor TH, Im T

Curr HIV Res. 2006 Jul;4(3):375-8.
Abstract
 

The changing face of HIV-associated lymphoma: what can we learn about optimal therapy
in the post highly active antiretroviral therapy era?
Clayton A, Mughal T.

Hematol Oncol. 2
005 Jun 30;22(3):111-120
Abstract
 
Pharmacokinetic interaction between chemotherapy for non-Hodgkin's lymphoma and
protease inhibitors in HIV-1-infected patients.
Cruciani M, Gatti G, Vaccher E, et al
J Antimicrob Chemother. 2005 Feb 22;
Abstract
 
Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and
pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's
lymphoma.
Toffoli G, Corona G, Cattarossi G. et al
Ann Oncol. 2004 Dec;15(12):1805-1809.
Abstract
 

Doxorubicin
       

     Journal Papers, Abstracts, and Commentaries  

 
Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active
antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's
lymphoma.

Xicoy B, Ribera JM, Miralles P, et al 

Haematologica.
2007 Feb;92(2):191-198.
Abstract

Liposome-Encapsulated Doxorubicin in Combination With Standard Agents
(cyclophosphamide, vincristine, prednisone) in Patients With Newly Diagnosed
AIDS-Related Non-Hodgkin's Lymphoma: Results of Therapy and Correlates of Response.
Levine AM, Tulpule A, Espina B, et al
Clin Oncol. 2004 Jul 1;22(13):2662-70.
Abstract


Rituximab
       

     Journal Papers, Abstracts, and Commentaries  

 
Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated
non-Hodgkin lymphoma: A pooled analysis of 15 prospective studies.

Castillo JJ, Echenique IA.

Am J Hematol
. 2011 Dec 17.
Abstract

Phase II Trial of CHOP Plus Rituximab in Patients With HIV-Associated Non-Hodgkin's
Lymphoma.
Boue F, Gabarre J, Gisselbrecht C, et al

J Clin Oncol. 2006 Aug 8;
Abstract

Rituximab does not improve clinical outcome in a randomized phase III trial of CHOP
with or without rituximab in patients with HIV-associated non-Hodgkin's lymphoma:
AIDS-malignancies consortium trial 010.
Kaplan LD, Lee JY, Ambinder RF, et al 
Blood. 2005 May 24;
Abstract

Rituximab plus infusional cyclophosphamide, doxorubicin and etoposide (R-CDE) in HIV-
associated non-Hodgkin's lymphoma: pooled results from three phase II trials.
Spina M, Jaeger U, Sparano JA.et al 
Blood. 2004 Nov 18;
Abstract
 
Infusional CDE with rituximab for the treatment of human immunodeficiency virus-
associated non-Hodgkin's lymphoma: preliminary results of a phase I/II study.

Tirelli U, Spina M, Jaeger U, et al.
Recent Results Cancer Res 2002;159:149-53
Abstract
 

Miscellaneous Therapies
       

     Journal Papers, Abstracts, and Commentaries  
 
 
Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathy
Sandoval-Sus JD, Mogollon-Duffo F, Patel A, et al
 
J Immunother Cancer
. 2017 Jun 20;5:49.
Abstract

Study on effectiveness of gemcitabine, dexamethasone, and cisplatin (GDP) for relapsed or refractory AIDS-related non-Hodgkin's lymphoma.
Zhong DT, Shi CM, Chen Q,  et al

Ann Hematol
. 2012 Jul 13..
Abstract

Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of
lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin
lymphoma.
Spina M, Chimienti E, Martellotta F,
et al
Cancer. 2010 Jan 27
Abstract.

Human immunodeficiency virus-associated diffuse non-Hodgkin's lymphoma in Venezuelan
patients: treatment with full-dose cyclophosphamide-doxorubicin-vincristine-prednisone
without routine use of granulocyte-colony stimulating factor.
Hernandez DE, Hernandez AE 
Eur J Cancer Care (Engl). 2006 Dec;15(5):493-6.
Abstract.

Treatment of AIDS Related Non-Hodgkin's Lymphoma with Combination Mitoguazone
Dihydrochloride and Low Dose Chop Chemotherapy: Results of a Phase II study.
Tulpule A, Espina BM, Pedro Santabarbara AB, et al
Invest New Drugs. 2004 Jan;22(1):63-8
Abstract.
 

High-Dose Cytosine-Arabinoside and Cisplatin Regimens as Salvage Therapy for
Refractory
or Relapsed AIDS-Related Non-Hodgkin's Lymphoma.
Bi J, Espina BM, Tulpule A et al.
J Acquir Immune Defic Syndr 2001 Dec  15;28(5):416-421
Abstract
 
Human immunodeficiency virus-related non-Hodgkin lymphoma: activity of infusional
cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40
patients.

Spina M, Vaccher E, Juzbasic S, Milan I, et al.
Cancer 2001 Jul 1;92(1):200-6
Abstract
 


Non-Hodgkin's Lymphoma Main New/Newsworthy Home Page

HIV-Associated Non-Hodgkin's Lymphoma Drugs